Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy

Rezum therapy is in emerging minimally invasive treatment for BPH. Complications of Rezum are underreported in the literature. We report a case of a 61-year-old male patient who presented to ED two months after Rezum with hematuria and clot retention. US showed prostate size of 315 g with cystic cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkeraithe, Fawaz, Bin Hamri, Saeed, Alsaleh, Faisal, Alasmari, Faisal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Endourology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188957/
https://www.ncbi.nlm.nih.gov/pubmed/35707222
http://dx.doi.org/10.1016/j.eucr.2022.102125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188957/
https://www.ncbi.nlm.nih.gov/pubmed/35707222
http://dx.doi.org/10.1016/j.eucr.2022.102125

Ejemplares similares